RESEARCH ON DIRECT MEDICAL COSTS AND RELATED FACTORS OF OUTPATIENTS WITH HELICOBACTER PYLORI-INDUCED GASTRIC-DUODENAL INFLAMMATION AND ULCERATION AT HOA HAO MEDIC CAN THO GENERAL HOSPITAL

Kiều Quyên Ngô , Minh Trung Nguyễn , Quang Lộc Duyên Võ , Văn Đệ Trần

Main Article Content

Abstract

Background: Helicobacter pylori-induced gastric-duodenal inflammation and ulceration are common diseases globally. These diseases are susceptible to recurrence and impose significant treatment costs on patients. Objectives: identifying the direct medical costs of outpatients with Helicobacter pylori-induced gastric-duodenal inflammation and ulceration and factors related to direct medical costs of outpatients with Helicobacter pylori-induced gastric-duodenal inflammation and ulceration in Hoa Hao-Medic Can Tho general hospital in 2022-2023. Materials and methods: a descriptive cross-sectional study was conducted on 408 prescriptions and cost sheets  of  outpatients with Helicobacter pylori-induced gastric-duodenal inflammation and ulceration in Hoa Hao-Medic Can Tho general hospital. Data were collected and analyzed by using Excel 2016 and SPSS 22.0 software. Results: total direct medical cost of  outpatients with Helicobacter pylori-induced gastric-duodenal inflammation and ulceration was 1,357,549,646 VND, the average direct medical cost per patient was 3,327,327 VND. Diagnostic imaging costs accounted for high proportions of 42.48%. Cormobidities and health insurance levels related to direct medical costs of  outpatients with Helicobacter pylori-induced gastric-duodenal inflammation and ulceration (p<0.05). Conclusions: This research elucidated the average direct medical costs of outpatients with Helicobacter pylori-induced gastric-duodenal inflammation and ulceration and underscored the significance of comorbidities and health insurance to direct medical costs.

Article Details

References

1. Hooi J. K. Y., Lai W. Y., Ng W. K, et al. (2017), “Global Prevealence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis”, Gastroenterology, 153(2), pp.420-429
2. Lanas A., Chan F. (2017), “Peptic ulcer disease”, Lancet, 390, pp. 613-624.
3. Sonnenberg A., Everhart J. E. (1997), “Health impact of peptic ulcer in the United States”, American Journal of Gastroenterology (Springer Nature), 92(4), pp. 614-620.
4. Dương Hiền Thảo Lan, Kha Hữu Nhân (2022), Nghiên cứu đặc điểm lâm sàng, hình ảnh nội soi và kết quả điều trị người bệnh viêm, loét dạ dày-tá tràng nhiễm helicobacter pylori bằng phác đồ 4 thuốc có bismuth, Tạp chí y dược học Cần Thơ, 53, tr. 53-60.
5. Trịnh Kiến Nhụy, Võ Thị Bé My (2022), Nghiên cứu việc sử dụng thuốc điều trị loét dạ dày tá tràng tại bệnh viện đa khoa tỉnh Trà Vinh, Tạp chí y học Việt Nam, 518(1), tr. 136-141.
6. Chính phủ (2018), Nghị định 146/2018/NĐ-CP Nghị định quy định chi tiết và hướng dẫn biện pháp thi hành một số điều của Luật Bảo hiểm y tế, Hà Nội.
7. Chính phủ (2022), Nghị định 38/2022/NĐ-CP Quy định mức lương tối thiểu đối với người lao động làm việc theo hợp đồng lao động, Hà Nội.
8. Hiroi, S., Sugano, K., Tanaka, S., & Kawakami, K. (2017). Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. BMJ open, 7(7), e015855.